Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.216 EUR | -1.82% | -.--% | -82.78% |
May. 28 | Mithra Delays AGM Amid Monetization Process | MT |
Apr. 29 | Mithra Pharmaceuticals to Postpone the Publication of Its Annual Report 2023 | CI |
Sales 2023 | 40.16M 43.55M | Sales 2024 * | 43.9M 47.61M | Capitalization | 14.93M 16.19M |
---|---|---|---|---|---|
Net income 2023 | -174M -189M | Net income 2024 * | -55M -59.65M | EV / Sales 2023 | 9.88 x |
Net Debt 2023 | 310M 336M | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 0.34 x |
P/E ratio 2023 * |
-0.16
x | P/E ratio 2024 * |
-
| Employees | 270 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 81.67% |
1 day | -1.82% | ||
3 months | -58.54% | ||
6 months | -80.75% | ||
Current year | -82.78% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 17-02-22 | |
Stijn Vlaminck
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-30 |
Graham Dixon
CTO | Chief Tech/Sci/R&D Officer | 63 | 19-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jacques Galloy
BRD | Director/Board Member | 53 | 23-05-28 |
Christian Homsy
CHM | Chairman | 65 | 23-05-28 |
Valérie Gordenne
BRD | Director/Board Member | 51 | 21-05-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.216 | -.--% | 0 |
24-05-30 | 0.216 | -.--% | 0 |
24-05-29 | 0.216 | -.--% | 0 |
24-05-28 | 0.216 | -.--% | 0 |
24-05-27 | 0.216 | -.--% | 0 |
Real-time Euronext Bruxelles, April 26, 2024 at 11:35 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-82.78% | 16.19M | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B |
- Stock Market
- Equities
- MITRA Stock